Global Therapeutic Recombinant Protein Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 14 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Therapeutic Recombinant Protein market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Therapeutic Recombinant Protein industry chain, the market status of Pharmaceutical Company (Hormones, Blood Clotting Factors), Research Institute (Hormones, Blood Clotting Factors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Recombinant Protein.

Regionally, the report analyzes the Therapeutic Recombinant Protein markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Recombinant Protein market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Therapeutic Recombinant Protein market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Recombinant Protein industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hormones, Blood Clotting Factors).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Recombinant Protein market.

Regional Analysis: The report involves examining the Therapeutic Recombinant Protein market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Recombinant Protein market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Therapeutic Recombinant Protein:
Company Analysis: Report covers individual Therapeutic Recombinant Protein players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Recombinant Protein This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Research Institute).

Technology Analysis: Report covers specific technologies relevant to Therapeutic Recombinant Protein. It assesses the current state, advancements, and potential future developments in Therapeutic Recombinant Protein areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Recombinant Protein market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Therapeutic Recombinant Protein market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Hormones
Blood Clotting Factors
Cytokines
Enzymes
Fusion Proteins
Others

Market segment by Application
Pharmaceutical Company
Research Institute
Others

Market segment by players, this report covers
Abcam
HALIX
Avantor
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne Corporation
Merck
ACROBiosystems
Abnova
Eurogentec (Kaneka Corporation)
Cytiva (Danaher )
Reprocell
GenScript
BPS Bioscience
Sino Biological

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Recombinant Protein product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Recombinant Protein, with revenue, gross margin and global market share of Therapeutic Recombinant Protein from 2018 to 2023.
Chapter 3, the Therapeutic Recombinant Protein competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Recombinant Protein market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Recombinant Protein.
Chapter 13, to describe Therapeutic Recombinant Protein research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Therapeutic Recombinant Protein
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Therapeutic Recombinant Protein by Type
        1.3.1 Overview: Global Therapeutic Recombinant Protein Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Therapeutic Recombinant Protein Consumption Value Market Share by Type in 2022
        1.3.3 Hormones
        1.3.4 Blood Clotting Factors
        1.3.5 Cytokines
        1.3.6 Enzymes
        1.3.7 Fusion Proteins
        1.3.8 Others
    1.4 Global Therapeutic Recombinant Protein Market by Application
        1.4.1 Overview: Global Therapeutic Recombinant Protein Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical Company
        1.4.3 Research Institute
        1.4.4 Others
    1.5 Global Therapeutic Recombinant Protein Market Size & Forecast
    1.6 Global Therapeutic Recombinant Protein Market Size and Forecast by Region
        1.6.1 Global Therapeutic Recombinant Protein Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Therapeutic Recombinant Protein Market Size by Region, (2018-2029)
        1.6.3 North America Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
        1.6.4 Europe Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
        1.6.6 South America Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Therapeutic Recombinant Protein Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Abcam
        2.1.1 Abcam Details
        2.1.2 Abcam Major Business
        2.1.3 Abcam Therapeutic Recombinant Protein Product and Solutions
        2.1.4 Abcam Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abcam Recent Developments and Future Plans
    2.2 HALIX
        2.2.1 HALIX Details
        2.2.2 HALIX Major Business
        2.2.3 HALIX Therapeutic Recombinant Protein Product and Solutions
        2.2.4 HALIX Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 HALIX Recent Developments and Future Plans
    2.3 Avantor
        2.3.1 Avantor Details
        2.3.2 Avantor Major Business
        2.3.3 Avantor Therapeutic Recombinant Protein Product and Solutions
        2.3.4 Avantor Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Avantor Recent Developments and Future Plans
    2.4 Miltenyi Biotec
        2.4.1 Miltenyi Biotec Details
        2.4.2 Miltenyi Biotec Major Business
        2.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Product and Solutions
        2.4.4 Miltenyi Biotec Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Miltenyi Biotec Recent Developments and Future Plans
    2.5 Thermo Fisher Scientific
        2.5.1 Thermo Fisher Scientific Details
        2.5.2 Thermo Fisher Scientific Major Business
        2.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Product and Solutions
        2.5.4 Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.6 Bio-Techne Corporation
        2.6.1 Bio-Techne Corporation Details
        2.6.2 Bio-Techne Corporation Major Business
        2.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Product and Solutions
        2.6.4 Bio-Techne Corporation Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bio-Techne Corporation Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Therapeutic Recombinant Protein Product and Solutions
        2.7.4 Merck Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 ACROBiosystems
        2.8.1 ACROBiosystems Details
        2.8.2 ACROBiosystems Major Business
        2.8.3 ACROBiosystems Therapeutic Recombinant Protein Product and Solutions
        2.8.4 ACROBiosystems Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 ACROBiosystems Recent Developments and Future Plans
    2.9 Abnova
        2.9.1 Abnova Details
        2.9.2 Abnova Major Business
        2.9.3 Abnova Therapeutic Recombinant Protein Product and Solutions
        2.9.4 Abnova Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Abnova Recent Developments and Future Plans
    2.10 Eurogentec (Kaneka Corporation)
        2.10.1 Eurogentec (Kaneka Corporation) Details
        2.10.2 Eurogentec (Kaneka Corporation) Major Business
        2.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product and Solutions
        2.10.4 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Eurogentec (Kaneka Corporation) Recent Developments and Future Plans
    2.11 Cytiva (Danaher )
        2.11.1 Cytiva (Danaher ) Details
        2.11.2 Cytiva (Danaher ) Major Business
        2.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Product and Solutions
        2.11.4 Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Cytiva (Danaher ) Recent Developments and Future Plans
    2.12 Reprocell
        2.12.1 Reprocell Details
        2.12.2 Reprocell Major Business
        2.12.3 Reprocell Therapeutic Recombinant Protein Product and Solutions
        2.12.4 Reprocell Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Reprocell Recent Developments and Future Plans
    2.13 GenScript
        2.13.1 GenScript Details
        2.13.2 GenScript Major Business
        2.13.3 GenScript Therapeutic Recombinant Protein Product and Solutions
        2.13.4 GenScript Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 GenScript Recent Developments and Future Plans
    2.14 BPS Bioscience
        2.14.1 BPS Bioscience Details
        2.14.2 BPS Bioscience Major Business
        2.14.3 BPS Bioscience Therapeutic Recombinant Protein Product and Solutions
        2.14.4 BPS Bioscience Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 BPS Bioscience Recent Developments and Future Plans
    2.15 Sino Biological
        2.15.1 Sino Biological Details
        2.15.2 Sino Biological Major Business
        2.15.3 Sino Biological Therapeutic Recombinant Protein Product and Solutions
        2.15.4 Sino Biological Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Sino Biological Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Therapeutic Recombinant Protein Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Therapeutic Recombinant Protein by Company Revenue
        3.2.2 Top 3 Therapeutic Recombinant Protein Players Market Share in 2022
        3.2.3 Top 6 Therapeutic Recombinant Protein Players Market Share in 2022
    3.3 Therapeutic Recombinant Protein Market: Overall Company Footprint Analysis
        3.3.1 Therapeutic Recombinant Protein Market: Region Footprint
        3.3.2 Therapeutic Recombinant Protein Market: Company Product Type Footprint
        3.3.3 Therapeutic Recombinant Protein Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Therapeutic Recombinant Protein Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Therapeutic Recombinant Protein Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Therapeutic Recombinant Protein Consumption Value Market Share by Application (2018-2023)
    5.2 Global Therapeutic Recombinant Protein Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
    6.2 North America Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
    6.3 North America Therapeutic Recombinant Protein Market Size by Country
        6.3.1 North America Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
        6.3.2 United States Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        6.3.3 Canada Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        6.3.4 Mexico Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
    7.2 Europe Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
    7.3 Europe Therapeutic Recombinant Protein Market Size by Country
        7.3.1 Europe Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
        7.3.2 Germany Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        7.3.3 France Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        7.3.5 Russia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        7.3.6 Italy Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Therapeutic Recombinant Protein Market Size by Region
        8.3.1 Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Region (2018-2029)
        8.3.2 China Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        8.3.3 Japan Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        8.3.4 South Korea Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        8.3.5 India Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        8.3.7 Australia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
    9.2 South America Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
    9.3 South America Therapeutic Recombinant Protein Market Size by Country
        9.3.1 South America Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
        9.3.2 Brazil Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        9.3.3 Argentina Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Therapeutic Recombinant Protein Market Size by Country
        10.3.1 Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Country (2018-2029)
        10.3.2 Turkey Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)
        10.3.4 UAE Therapeutic Recombinant Protein Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Therapeutic Recombinant Protein Market Drivers
    11.2 Therapeutic Recombinant Protein Market Restraints
    11.3 Therapeutic Recombinant Protein Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Therapeutic Recombinant Protein Industry Chain
    12.2 Therapeutic Recombinant Protein Upstream Analysis
    12.3 Therapeutic Recombinant Protein Midstream Analysis
    12.4 Therapeutic Recombinant Protein Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Therapeutic Recombinant Protein Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Therapeutic Recombinant Protein Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Therapeutic Recombinant Protein Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Therapeutic Recombinant Protein Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Abcam Company Information, Head Office, and Major Competitors
    Table 6. Abcam Major Business
    Table 7. Abcam Therapeutic Recombinant Protein Product and Solutions
    Table 8. Abcam Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Abcam Recent Developments and Future Plans
    Table 10. HALIX Company Information, Head Office, and Major Competitors
    Table 11. HALIX Major Business
    Table 12. HALIX Therapeutic Recombinant Protein Product and Solutions
    Table 13. HALIX Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. HALIX Recent Developments and Future Plans
    Table 15. Avantor Company Information, Head Office, and Major Competitors
    Table 16. Avantor Major Business
    Table 17. Avantor Therapeutic Recombinant Protein Product and Solutions
    Table 18. Avantor Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Avantor Recent Developments and Future Plans
    Table 20. Miltenyi Biotec Company Information, Head Office, and Major Competitors
    Table 21. Miltenyi Biotec Major Business
    Table 22. Miltenyi Biotec Therapeutic Recombinant Protein Product and Solutions
    Table 23. Miltenyi Biotec Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Miltenyi Biotec Recent Developments and Future Plans
    Table 25. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
    Table 26. Thermo Fisher Scientific Major Business
    Table 27. Thermo Fisher Scientific Therapeutic Recombinant Protein Product and Solutions
    Table 28. Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Thermo Fisher Scientific Recent Developments and Future Plans
    Table 30. Bio-Techne Corporation Company Information, Head Office, and Major Competitors
    Table 31. Bio-Techne Corporation Major Business
    Table 32. Bio-Techne Corporation Therapeutic Recombinant Protein Product and Solutions
    Table 33. Bio-Techne Corporation Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Bio-Techne Corporation Recent Developments and Future Plans
    Table 35. Merck Company Information, Head Office, and Major Competitors
    Table 36. Merck Major Business
    Table 37. Merck Therapeutic Recombinant Protein Product and Solutions
    Table 38. Merck Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Merck Recent Developments and Future Plans
    Table 40. ACROBiosystems Company Information, Head Office, and Major Competitors
    Table 41. ACROBiosystems Major Business
    Table 42. ACROBiosystems Therapeutic Recombinant Protein Product and Solutions
    Table 43. ACROBiosystems Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. ACROBiosystems Recent Developments and Future Plans
    Table 45. Abnova Company Information, Head Office, and Major Competitors
    Table 46. Abnova Major Business
    Table 47. Abnova Therapeutic Recombinant Protein Product and Solutions
    Table 48. Abnova Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Abnova Recent Developments and Future Plans
    Table 50. Eurogentec (Kaneka Corporation) Company Information, Head Office, and Major Competitors
    Table 51. Eurogentec (Kaneka Corporation) Major Business
    Table 52. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product and Solutions
    Table 53. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Eurogentec (Kaneka Corporation) Recent Developments and Future Plans
    Table 55. Cytiva (Danaher ) Company Information, Head Office, and Major Competitors
    Table 56. Cytiva (Danaher ) Major Business
    Table 57. Cytiva (Danaher ) Therapeutic Recombinant Protein Product and Solutions
    Table 58. Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Cytiva (Danaher ) Recent Developments and Future Plans
    Table 60. Reprocell Company Information, Head Office, and Major Competitors
    Table 61. Reprocell Major Business
    Table 62. Reprocell Therapeutic Recombinant Protein Product and Solutions
    Table 63. Reprocell Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Reprocell Recent Developments and Future Plans
    Table 65. GenScript Company Information, Head Office, and Major Competitors
    Table 66. GenScript Major Business
    Table 67. GenScript Therapeutic Recombinant Protein Product and Solutions
    Table 68. GenScript Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. GenScript Recent Developments and Future Plans
    Table 70. BPS Bioscience Company Information, Head Office, and Major Competitors
    Table 71. BPS Bioscience Major Business
    Table 72. BPS Bioscience Therapeutic Recombinant Protein Product and Solutions
    Table 73. BPS Bioscience Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. BPS Bioscience Recent Developments and Future Plans
    Table 75. Sino Biological Company Information, Head Office, and Major Competitors
    Table 76. Sino Biological Major Business
    Table 77. Sino Biological Therapeutic Recombinant Protein Product and Solutions
    Table 78. Sino Biological Therapeutic Recombinant Protein Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Sino Biological Recent Developments and Future Plans
    Table 80. Global Therapeutic Recombinant Protein Revenue (USD Million) by Players (2018-2023)
    Table 81. Global Therapeutic Recombinant Protein Revenue Share by Players (2018-2023)
    Table 82. Breakdown of Therapeutic Recombinant Protein by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in Therapeutic Recombinant Protein, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 84. Head Office of Key Therapeutic Recombinant Protein Players
    Table 85. Therapeutic Recombinant Protein Market: Company Product Type Footprint
    Table 86. Therapeutic Recombinant Protein Market: Company Product Application Footprint
    Table 87. Therapeutic Recombinant Protein New Market Entrants and Barriers to Market Entry
    Table 88. Therapeutic Recombinant Protein Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global Therapeutic Recombinant Protein Consumption Value (USD Million) by Type (2018-2023)
    Table 90. Global Therapeutic Recombinant Protein Consumption Value Share by Type (2018-2023)
    Table 91. Global Therapeutic Recombinant Protein Consumption Value Forecast by Type (2024-2029)
    Table 92. Global Therapeutic Recombinant Protein Consumption Value by Application (2018-2023)
    Table 93. Global Therapeutic Recombinant Protein Consumption Value Forecast by Application (2024-2029)
    Table 94. North America Therapeutic Recombinant Protein Consumption Value by Type (2018-2023) & (USD Million)
    Table 95. North America Therapeutic Recombinant Protein Consumption Value by Type (2024-2029) & (USD Million)
    Table 96. North America Therapeutic Recombinant Protein Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. North America Therapeutic Recombinant Protein Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. North America Therapeutic Recombinant Protein Consumption Value by Country (2018-2023) & (USD Million)
    Table 99. North America Therapeutic Recombinant Protein Consumption Value by Country (2024-2029) & (USD Million)
    Table 100. Europe Therapeutic Recombinant Protein Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Europe Therapeutic Recombinant Protein Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Europe Therapeutic Recombinant Protein Consumption Value by Application (2018-2023) & (USD Million)
    Table 103. Europe Therapeutic Recombinant Protein Consumption Value by Application (2024-2029) & (USD Million)
    Table 104. Europe Therapeutic Recombinant Protein Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Therapeutic Recombinant Protein Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Type (2018-2023) & (USD Million)
    Table 107. Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Type (2024-2029) & (USD Million)
    Table 108. Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Application (2018-2023) & (USD Million)
    Table 109. Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Application (2024-2029) & (USD Million)
    Table 110. Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Region (2018-2023) & (USD Million)
    Table 111. Asia-Pacific Therapeutic Recombinant Protein Consumption Value by Region (2024-2029) & (USD Million)
    Table 112. South America Therapeutic Recombinant Protein Consumption Value by Type (2018-2023) & (USD Million)
    Table 113. South America Therapeutic Recombinant Protein Consumption Value by Type (2024-2029) & (USD Million)
    Table 114. South America Therapeutic Recombinant Protein Consumption Value by Application (2018-2023) & (USD Million)
    Table 115. South America Therapeutic Recombinant Protein Consumption Value by Application (2024-2029) & (USD Million)
    Table 116. South America Therapeutic Recombinant Protein Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. South America Therapeutic Recombinant Protein Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Type (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Type (2024-2029) & (USD Million)
    Table 120. Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Application (2018-2023) & (USD Million)
    Table 121. Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Application (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Country (2018-2023) & (USD Million)
    Table 123. Middle East & Africa Therapeutic Recombinant Protein Consumption Value by Country (2024-2029) & (USD Million)
    Table 124. Therapeutic Recombinant Protein Raw Material
    Table 125. Key Suppliers of Therapeutic Recombinant Protein Raw Materials
List of Figures
    Figure 1. Therapeutic Recombinant Protein Picture
    Figure 2. Global Therapeutic Recombinant Protein Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Therapeutic Recombinant Protein Consumption Value Market Share by Type in 2022
    Figure 4. Hormones
    Figure 5. Blood Clotting Factors
    Figure 6. Cytokines
    Figure 7. Enzymes
    Figure 8. Fusion Proteins
    Figure 9. Others
    Figure 10. Global Therapeutic Recombinant Protein Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 11. Therapeutic Recombinant Protein Consumption Value Market Share by Application in 2022
    Figure 12. Pharmaceutical Company Picture
    Figure 13. Research Institute Picture
    Figure 14. Others Picture
    Figure 15. Global Therapeutic Recombinant Protein Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 16. Global Therapeutic Recombinant Protein Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 17. Global Market Therapeutic Recombinant Protein Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 18. Global Therapeutic Recombinant Protein Consumption Value Market Share by Region (2018-2029)
    Figure 19. Global Therapeutic Recombinant Protein Consumption Value Market Share by Region in 2022
    Figure 20. North America Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 21. Europe Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 22. Asia-Pacific Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 23. South America Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 24. Middle East and Africa Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 25. Global Therapeutic Recombinant Protein Revenue Share by Players in 2022
    Figure 26. Therapeutic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 27. Global Top 3 Players Therapeutic Recombinant Protein Market Share in 2022
    Figure 28. Global Top 6 Players Therapeutic Recombinant Protein Market Share in 2022
    Figure 29. Global Therapeutic Recombinant Protein Consumption Value Share by Type (2018-2023)
    Figure 30. Global Therapeutic Recombinant Protein Market Share Forecast by Type (2024-2029)
    Figure 31. Global Therapeutic Recombinant Protein Consumption Value Share by Application (2018-2023)
    Figure 32. Global Therapeutic Recombinant Protein Market Share Forecast by Application (2024-2029)
    Figure 33. North America Therapeutic Recombinant Protein Consumption Value Market Share by Type (2018-2029)
    Figure 34. North America Therapeutic Recombinant Protein Consumption Value Market Share by Application (2018-2029)
    Figure 35. North America Therapeutic Recombinant Protein Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 37. Canada Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 38. Mexico Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 39. Europe Therapeutic Recombinant Protein Consumption Value Market Share by Type (2018-2029)
    Figure 40. Europe Therapeutic Recombinant Protein Consumption Value Market Share by Application (2018-2029)
    Figure 41. Europe Therapeutic Recombinant Protein Consumption Value Market Share by Country (2018-2029)
    Figure 42. Germany Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 43. France Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 44. United Kingdom Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 45. Russia Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 46. Italy Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 47. Asia-Pacific Therapeutic Recombinant Protein Consumption Value Market Share by Type (2018-2029)
    Figure 48. Asia-Pacific Therapeutic Recombinant Protein Consumption Value Market Share by Application (2018-2029)
    Figure 49. Asia-Pacific Therapeutic Recombinant Protein Consumption Value Market Share by Region (2018-2029)
    Figure 50. China Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 51. Japan Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 52. South Korea Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 53. India Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 54. Southeast Asia Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 55. Australia Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 56. South America Therapeutic Recombinant Protein Consumption Value Market Share by Type (2018-2029)
    Figure 57. South America Therapeutic Recombinant Protein Consumption Value Market Share by Application (2018-2029)
    Figure 58. South America Therapeutic Recombinant Protein Consumption Value Market Share by Country (2018-2029)
    Figure 59. Brazil Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 60. Argentina Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 61. Middle East and Africa Therapeutic Recombinant Protein Consumption Value Market Share by Type (2018-2029)
    Figure 62. Middle East and Africa Therapeutic Recombinant Protein Consumption Value Market Share by Application (2018-2029)
    Figure 63. Middle East and Africa Therapeutic Recombinant Protein Consumption Value Market Share by Country (2018-2029)
    Figure 64. Turkey Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 65. Saudi Arabia Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 66. UAE Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 67. Therapeutic Recombinant Protein Market Drivers
    Figure 68. Therapeutic Recombinant Protein Market Restraints
    Figure 69. Therapeutic Recombinant Protein Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of Therapeutic Recombinant Protein in 2022
    Figure 72. Manufacturing Process Analysis of Therapeutic Recombinant Protein
    Figure 73. Therapeutic Recombinant Protein Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abcam
HALIX
Avantor
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne Corporation
Merck
ACROBiosystems
Abnova
Eurogentec (Kaneka Corporation)
Cytiva (Danaher )
Reprocell
GenScript
BPS Bioscience
Sino Biological

Related Reports

Global Therapeutic Recombinant Protein Supply, Demand and Key Producers, 2023-2029

Global Therapeutic Recombinant Protein Supply, Demand and Key Producers, 2023-2029

date 14 Aug 2023

date Medical Care

The global Therapeutic Recombinant Protein market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Therapeutic Recombinant Protein Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Therapeutic Recombinant Protein Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 18 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Therapeutic Recombinant Protein market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Therapeutic Recombinant Protein Supply, Demand and Key Producers, 2024-2030

Global Therapeutic Recombinant Protein Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Medical Care

The global Therapeutic Recombinant Protein market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Therapeutic Recombinant Protein

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>